KR101471022B1 - 손발바닥 홍반성감각장애의 치료를 위한 알로퓨리놀의 용도 - Google Patents

손발바닥 홍반성감각장애의 치료를 위한 알로퓨리놀의 용도 Download PDF

Info

Publication number
KR101471022B1
KR101471022B1 KR1020087032168A KR20087032168A KR101471022B1 KR 101471022 B1 KR101471022 B1 KR 101471022B1 KR 1020087032168 A KR1020087032168 A KR 1020087032168A KR 20087032168 A KR20087032168 A KR 20087032168A KR 101471022 B1 KR101471022 B1 KR 101471022B1
Authority
KR
South Korea
Prior art keywords
treatment
ppe
chemotherapy
pharmaceutical composition
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020087032168A
Other languages
English (en)
Korean (ko)
Other versions
KR20090031697A (ko
Inventor
욜란다 로데메르
Original Assignee
노베라 파르마, 에스. 엘.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06011432A external-priority patent/EP1862166A1/en
Application filed by 노베라 파르마, 에스. 엘. filed Critical 노베라 파르마, 에스. 엘.
Publication of KR20090031697A publication Critical patent/KR20090031697A/ko
Application granted granted Critical
Publication of KR101471022B1 publication Critical patent/KR101471022B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020087032168A 2006-06-01 2008-12-31 손발바닥 홍반성감각장애의 치료를 위한 알로퓨리놀의 용도 Expired - Fee Related KR101471022B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06011432.9 2006-06-01
EP06011432A EP1862166A1 (en) 2006-06-01 2006-06-01 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
EP07107744.0 2007-05-08
EP07107744 2007-05-08
PCT/EP2007/055367 WO2007138103A1 (en) 2006-06-01 2007-05-31 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia

Publications (2)

Publication Number Publication Date
KR20090031697A KR20090031697A (ko) 2009-03-27
KR101471022B1 true KR101471022B1 (ko) 2014-12-09

Family

ID=38512579

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087032168A Expired - Fee Related KR101471022B1 (ko) 2006-06-01 2008-12-31 손발바닥 홍반성감각장애의 치료를 위한 알로퓨리놀의 용도

Country Status (21)

Country Link
US (3) US7973046B2 (enExample)
EP (1) EP2035006B1 (enExample)
JP (3) JP5028480B2 (enExample)
KR (1) KR101471022B1 (enExample)
AT (1) ATE457729T1 (enExample)
AU (1) AU2007267069B2 (enExample)
CA (1) CA2654270C (enExample)
CY (1) CY1110336T1 (enExample)
DE (1) DE602007004849D1 (enExample)
DK (1) DK2035006T3 (enExample)
ES (1) ES2341379T3 (enExample)
HR (1) HRP20100210T1 (enExample)
IL (1) IL195472A (enExample)
MX (1) MX2008015266A (enExample)
NZ (1) NZ573248A (enExample)
PL (1) PL2035006T3 (enExample)
PT (1) PT2035006E (enExample)
RS (1) RS51252B (enExample)
RU (1) RU2438673C2 (enExample)
SI (1) SI2035006T1 (enExample)
WO (1) WO2007138103A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246057A1 (en) 2009-04-29 2010-11-03 Nobera Pharma, S.L. Use of allopurinol for the treatment of hand foot skin reaction
US9220713B2 (en) 2009-10-16 2015-12-29 Duke University Compositions and methods for the treatment of drug-induced hand-foot syndrome
EP2368549A1 (en) 2010-03-25 2011-09-28 BioAlliance Pharma Treating hand-foot syndrome and related pathologies using clonidine or its derivatives
US8729056B2 (en) 2010-03-31 2014-05-20 Ono Pharmaceutical Co., Ltd. Preventive and/or therapeutic agent of hand-foot syndrome
JP4761000B1 (ja) * 2010-11-08 2011-08-31 小野薬品工業株式会社 手足症候群の予防および／または治療剤
JP4983989B2 (ja) * 2010-03-31 2012-07-25 小野薬品工業株式会社 手足症候群の予防および治療剤
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
EP2712613B1 (en) * 2012-09-28 2017-02-08 Pharmadab d.o.o. Vitamin K1 and uses thereof
CA3017432A1 (en) * 2016-03-28 2017-10-05 Vidac Pharma Ltd. Stable pharmaceutical compositions for topical administration and uses thereof
TW201927292A (zh) 2017-12-13 2019-07-16 大陸商上海小午醫藥科技有限公司 一種用於預防或治療與ｅｇｆｒ被抑制相關疾病的方法
TW201943428A (zh) 2018-04-16 2019-11-16 大陸商上海岸闊醫藥科技有限公司 預防或治療腫瘤療法副作用的方法
RU2722396C2 (ru) * 2018-07-11 2020-05-29 Федеральное государственное бюджетное учреждение дополнительного профессионального образования "Центральная государственная медицинская академия" Управления делами Президента Российской Федерации (ФГБУ ДПО "ЦГМА") Способ лечения пальмарно-плантарной эритродизестезии

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018102A2 (en) * 2001-08-29 2003-03-06 Vectura Limited Topical administration device

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3011A (en) * 1843-03-21 Improvement in water-wheels
ATE66147T1 (de) 1987-02-13 1991-08-15 Allergan Pharma Verwendung von pteridinen und/oder purinen oder eines xanthinoxidase-hemmers zur herstellung eines arzneimittels zur behandlung von genetisch bedingten degenerativen netzhauterkrankungen.
JPH03106817A (ja) 1989-09-20 1991-05-07 Nippon Kayaku Co Ltd アロプリノール製剤
JPH066700A (ja) 1992-06-22 1994-01-14 Fujitsu General Ltd ハイビジョン受像機
GB9218711D0 (en) 1992-09-04 1992-10-21 Salim Aws S M Skin cancer treatment
WO1994005293A1 (en) 1992-09-04 1994-03-17 Aws Shakir Mustafa Salim Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
JP3106817B2 (ja) 1993-11-02 2000-11-06 富士電機株式会社 漏電遮断器
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6060083A (en) 1999-04-01 2000-05-09 Topical Technologies, Inc. Topical DMSO treatment for palmar-plantar erythrodysethesia
ATE357207T1 (de) 2000-06-20 2007-04-15 Henkel Kgaa Verwendung von vitamin b6-derivaten zur haarstrukturverbesserung
EP1343492B1 (en) 2000-11-22 2006-02-01 Rxkinetix, Inc. Treatment of mucositis
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
CN1596111A (zh) 2001-11-29 2005-03-16 桑得医药品公司 减轻化疗引起的不良效果的组合物及方法
DE10200578A1 (de) * 2002-01-09 2003-07-10 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme
US6979688B2 (en) 2002-02-12 2005-12-27 Ford John P Treatment method against side-effects of chemotherapy
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
JP2007501864A (ja) 2003-06-11 2007-02-01 ノバセア インコーポレイティッド 活性ビタミンｄ化合物単独または他の治療薬との併用による、免疫介在疾患の治療法
EP1631146A4 (en) 2003-06-11 2006-12-06 Novacea Inc TREATMENT OF CANCER USING ACTIVE VITAMIN COMPOUNDS ASSOCIATED WITH RADIOTHERAPEUTIC AGENTS AND TREATMENTS
US20050148910A1 (en) 2003-12-24 2005-07-07 Gregory Skover Apparatus having a skin-contactable element containing an agent
EP1737482A4 (en) * 2004-03-01 2010-09-15 Lumen Therapeutics Llc COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
JP4405326B2 (ja) 2004-06-28 2010-01-27 株式会社東芝 ランドリー機器
EP1796660B1 (en) * 2004-09-17 2016-11-23 BioMAS Ltd. Use of ammonium trichloro(dioxyethylene-o,o')tellurate (as101) for the inhibition of interleukin-1beta-converting enzyme

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018102A2 (en) * 2001-08-29 2003-03-06 Vectura Limited Topical administration device

Also Published As

Publication number Publication date
SI2035006T1 (sl) 2010-04-30
US7973046B2 (en) 2011-07-05
EP2035006A1 (en) 2009-03-18
ATE457729T1 (de) 2010-03-15
US20090306097A1 (en) 2009-12-10
RU2438673C2 (ru) 2012-01-10
RU2008152341A (ru) 2010-07-20
AU2007267069B2 (en) 2011-08-11
MX2008015266A (es) 2009-02-10
JP2009542581A (ja) 2009-12-03
US8557829B2 (en) 2013-10-15
JP5389980B2 (ja) 2014-01-15
CY1110336T1 (el) 2015-01-14
US20140011820A1 (en) 2014-01-09
RS51252B (sr) 2010-12-31
CA2654270A1 (en) 2007-12-06
PT2035006E (pt) 2010-04-22
WO2007138103A1 (en) 2007-12-06
JP2012180370A (ja) 2012-09-20
JP5028480B2 (ja) 2012-09-19
IL195472A0 (en) 2011-08-01
DK2035006T3 (da) 2010-04-19
HRP20100210T1 (hr) 2010-05-31
DE602007004849D1 (de) 2010-04-01
JP2014028851A (ja) 2014-02-13
IL195472A (en) 2012-04-30
NZ573248A (en) 2011-01-28
KR20090031697A (ko) 2009-03-27
US20110224237A1 (en) 2011-09-15
AU2007267069A1 (en) 2007-12-06
PL2035006T3 (pl) 2010-07-30
ES2341379T3 (es) 2010-06-18
CA2654270C (en) 2014-05-13
EP2035006B1 (en) 2010-02-17

Similar Documents

Publication Publication Date Title
KR101471022B1 (ko) 손발바닥 홍반성감각장애의 치료를 위한 알로퓨리놀의 용도
AU2016228193A1 (en) Use of allopurinol for the treatment of hand foot skin reaction
CN101460172B (zh) 别嘌醇在制备治疗手足综合征的药物中的用途
HK1168042B (en) Use of allopurinol for the treatment of hand foot skin reaction

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20171204

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20171204